BIOMAT Database Logo BIOMAT Database Logo

Myasthenia gravis following iron chelation therapy with intravenous desferrioxamine. 1995

K Krishnan, and J D Trobe, and P T Adams

UI MeSH Term Description Entries
D008297 Male Males
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D011729 Pyridostigmine Bromide A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants. Mestinon,Pyridostigmine,Bromide, Pyridostigmine
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000756 Anemia, Sideroblastic Anemia characterized by the presence of erythroblasts containing excessive deposits of iron in the marrow. Anemias, Sideroblastic,Sideroblastic Anemia,Sideroblastic Anemias

Related Publications

K Krishnan, and J D Trobe, and P T Adams
[Rare indications for iron chelation therapy with desferrioxamine].
January 1991, Padiatrie und Padologie,
K Krishnan, and J D Trobe, and P T Adams
Intensive iron-chelation therapy with desferrioxamine in iron-loading anaemias.
January 1978, Clinical science and molecular medicine,
K Krishnan, and J D Trobe, and P T Adams
Iron chelation with oral desferrioxamine.
October 1980, Lancet (London, England),
K Krishnan, and J D Trobe, and P T Adams
Iron chelation with oral desferrioxamine.
September 1980, Lancet (London, England),
K Krishnan, and J D Trobe, and P T Adams
Overview of iron chelation therapy with desferrioxamine and deferiprone.
January 2009, Hemoglobin,
K Krishnan, and J D Trobe, and P T Adams
Specific chelation therapy with desferrioxamine in massive iron overdose.
March 1969, Applied therapeutics,
K Krishnan, and J D Trobe, and P T Adams
Cerebral infarction following intravenous immunoglobulin therapy for myasthenia gravis.
June 1994, Neurology,
K Krishnan, and J D Trobe, and P T Adams
Iron overload and desferrioxamine chelation therapy in beta-thalassemia intermedia.
November 1981, European journal of pediatrics,
K Krishnan, and J D Trobe, and P T Adams
Combined chelation therapy with deferiprone and desferrioxamine in iron overloaded beta-thalassemia patients.
April 2004, Haematologica,
K Krishnan, and J D Trobe, and P T Adams
High-dose intravenous immunoglobulin therapy for myasthenia gravis.
January 1998, Journal of neurology,
Copied contents to your clipboard!